More on XERS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (7.8 Score)
- Holders

Upcoming Events

- Earnings (8/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Xeris Pharmaceuticals Inc. (NQ:XERS)
Delayed: 5.81 -0.23 (3.81%)
Prev. Close $6.04  
Open$5.95 
52 Wk High$ 
52 Wk Low$ 
Day High$5.96 
Day Low$5.70 
P/E N/A  
EPS$ 
Volume1,796,749 

Friends, Peers and Foes (?): VRNA, ANAB, DSGN, HLXA PSTX (more...)

Mar 5, 2026 07:18 PM Form 4 Xeris Biopharma Holdings For: Mar 05 Filed by: Pieper Steven
Mar 4, 2026 05:29 PM Form 4 Xeris Biopharma Holdings For: Mar 02 Filed by: Hecht Beth
Mar 2, 2026 04:36 PM Form 144 Xeris Biopharma Holdings Filed by: Hecht Beth
Mar 2, 2026 04:28 PM Form S-8 Xeris Biopharma Holdings
Mar 2, 2026 04:26 PM Form 10-K Xeris Biopharma Holdings For: Dec 31
Mar 2, 2026 07:09 AM Form 8-K Xeris Biopharma Holdings For: Mar 02
Mar 2, 2026 07:03 AM Xeris Pharmaceuticals Inc. (XERS) Tops Q4 EPS by 4c, provides guidance
Mar 2, 2026 07:00 AM Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance
Feb 27, 2026 06:07 AM Form 8-K Xeris Biopharma Holdings For: Feb 26
Feb 26, 2026 06:40 PM Xeris sues generic drugmakers over Recorlev patents
View All Articles

Entities mentioned with XERS

View All Entities